The goal of this study is to to learn more about what assessments would be useful to measure for NM and what normally happens during the lives of people with NM to support future clinical trial development.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
To observe the natural clinical progression of NM in patients not receiving any disease-modifying intervention
Timeframe: Baseline, 6 months (age <18 years only), 12months, 18 months (age <18 years only) 24 months, 36 months.
To observe the natural clinical progression of NM in patients not receiving any disease-modifying intervention
Timeframe: Baseline, 6 months (age <18 years only), 12months, 18 months (age <18 years only) 24 months, 36 months.
To observe the natural clinical progression of NM in patients not receiving any disease-modifying intervention
Timeframe: Baseline, 6 months (age <18 years only), 12months, 18 months (age <18 years only) 24 months, 36 months.
To observe the natural clinical progression of NM in patients not receiving any disease-modifying intervention
Timeframe: Baseline, 6 months (age <18 years only), 12months, 18 months (age <18 years only) 24 months, 36 months.
To observe the natural clinical progression of NM in patients not receiving any disease-modifying intervention
Timeframe: Baseline, 6 months (age <18 years only), 12months, 18 months (age <18 years only) 24 months, 36 months.